FDA approves Eli Lilly's oral obesity pill

J. Carlisle Larsen explains Foundéo's approval, trial weight-loss results, pricing, and rapid 50-day FDA review under a new pilot program.

Play episode from 01:45

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!